TY - JOUR T1 - The prevalence and burden of interstitial lung diseases in the USA JF - ERJ Open Research JO - erjor DO - 10.1183/23120541.00630-2021 VL - 8 IS - 1 SP - 00630-2021 AU - Niranjan Jeganathan AU - Matheni Sathananthan Y1 - 2022/01/01 UR - http://openres.ersjournals.com/content/8/1/00630-2021.abstract N2 - Interstitial lung diseases (ILDs) are a heterogeneous group of diseases (i.e. idiopathic interstitial pneumonias, autoimmune ILDs, environmental exposure-related ILDs, sarcoidosis) but share several common clinical and pathophysiological features [1, 2]. ILDs are associated with significant morbidity, mortality and increased financial burden [3, 4].Interstitial lung diseases (ILDs) are a significant contributor to disability and deaths in the USA. The prevalence and deaths from ILDs have increased but when adjusted for age, have been stable since 2010. https://bit.ly/3IDlZrg ER -